U.S. Markets open in 4 hrs 44 mins

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.54+0.37 (+3.64%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 322.40
52 Week Low 39.87
50-Day Moving Average 311.21
200-Day Moving Average 313.53

Share Statistics

Avg Vol (3 month) 31.27M
Avg Vol (10 day) 31.23M
Shares Outstanding 5101.83M
Implied Shares Outstanding 6N/A
Float 879.8M
% Held by Insiders 10.15%
% Held by Institutions 1104.67%
Shares Short (Sep 14, 2021) 426.37M
Short Ratio (Sep 14, 2021) 424.5
Short % of Float (Sep 14, 2021) 429.60%
Short % of Shares Outstanding (Sep 14, 2021) 425.87%
Shares Short (prior month Aug 12, 2021) 425.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 12, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin -281.99%
Operating Margin (ttm)-272.99%

Management Effectiveness

Return on Assets (ttm)-33.85%
Return on Equity (ttm)-96.72%

Income Statement

Revenue (ttm)83.03M
Revenue Per Share (ttm)0.89
Quarterly Revenue Growth (yoy)-1.00%
Gross Profit (ttm)-120.88M
EBITDA -223.71M
Net Income Avi to Common (ttm)-234.14M
Diluted EPS (ttm)-2.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)257.68M
Total Cash Per Share (mrq)2.53
Total Debt (mrq)165.16M
Total Debt/Equity (mrq)103.15
Current Ratio (mrq)4.47
Book Value Per Share (mrq)2.15

Cash Flow Statement

Operating Cash Flow (ttm)-199.54M
Levered Free Cash Flow (ttm)-114.63M